DECAY-ACCELERATING FACTOR (CD55), A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED COMPLEMENT REGULATORY PROTEIN, IS A RECEPTOR FOR SEVERAL ECHOVIRUSES

被引:260
作者
BERGELSON, JM
CHAN, M
SOLOMON, KR
STJOHN, NF
LIN, HM
FINBERG, RW
机构
[1] Laboratory of Infectious Diseases, Dana-Farber Cancer Institute, Harvard Medical School, Boston
关键词
VIRUS RECEPTOR; PICORNAVIRUS; ECHOVIRUS; 7;
D O I
10.1073/pnas.91.13.6245
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Echoviruses are human pathogens belonging to the picornavirus family. Decay-accelerating fatter (DAF) is a glycosylphosphatidylinositol (GPI)-anchored surface protein that protects cells from lysis by autologous complement. Anti-DAF monoclonal antibodies prevented echovirus 7 attachment to susceptible cells and protected cells from infection. HeLa cells specifically lost the capacity to bind echovirus 7 when treated with phosphatidylinositol-specific phospholipase C, an enzyme that releases GPI-anchored proteins from the cell surface, indicating that the virus receptor, like DAF, is a GPI-anchored protein. Although Chinese hamster ovary cells do not bind echovirus 7, transfectants expressing human DAF bound virus efficiently, and binding was prevented by pretreatment with an anti-DAF monoclonal antibody. Anti-DAF antibodies prevented infection by at least six echovirus serotypes. These results indicate that DAF is the receptor mediating attachment and infection by several echoviruses.
引用
收藏
页码:6245 / 6248
页数:4
相关论文
共 29 条
[11]  
HAREGEWOIN A, 1994, IN PRESS CELL IMMUNO
[13]   ENDOCYTOSIS OF GLYCOPHOSPHOLIPID-ANCHORED AND TRANSMEMBRANE FORMS OF CD4 BY DIFFERENT ENDOCYTIC PATHWAYS [J].
KELLER, GA ;
SIEGEL, MW ;
CARAS, IW .
EMBO JOURNAL, 1992, 11 (03) :863-874
[14]   DISTRIBUTION OF DECAY-ACCELERATING FACTOR IN THE PERIPHERAL-BLOOD OF NORMAL INDIVIDUALS AND PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA [J].
KINOSHITA, T ;
MEDOF, ME ;
SILBER, R ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) :75-92
[15]   PHOSPHOLIPID-ANCHORED AND TRANSMEMBRANE VERSIONS OF EITHER DECAY-ACCELERATING FACTOR OR MEMBRANE COFACTOR PROTEIN SHOW EQUAL EFFICIENCY IN PROTECTION FROM COMPLEMENT-MEDIATED CELL-DAMAGE [J].
LUBLIN, DM ;
COYNE, KE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :35-44
[16]  
LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.iy.07.040189.000343
[17]   AMELIORATION OF LYTIC ABNORMALITIES OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA WITH DECAY-ACCELERATING FACTOR [J].
MEDOF, ME ;
KINOSHITA, T ;
SILBER, R ;
NUSSENZWEIG, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (09) :2980-2984
[18]   CLONING AND CHARACTERIZATION OF CDNAS ENCODING THE COMPLETE SEQUENCE OF DECAY-ACCELERATING FACTOR OF HUMAN-COMPLEMENT [J].
MEDOF, ME ;
LUBLIN, DM ;
HOLERS, VM ;
AYERS, DJ ;
GETTY, RR ;
LEYKAM, JF ;
ATKINSON, JP ;
TYKOCINSKI, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (07) :2007-2011
[19]   IDENTIFICATION OF THE COMPLEMENT DECAY-ACCELERATING FACTOR (DAF) ON EPITHELIUM AND GLANDULAR CELLS AND IN BODY-FLUIDS [J].
MEDOF, ME ;
WALTER, EI ;
RUTGERS, JL ;
KNOWLES, DM ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) :848-864
[20]  
NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184